Turn to the nation's most objective and informative daily environmental news resource to learn how the United States and key players around the world are responding to the environmental...
By Pat Rizzuto
Aug. 15 — Three more new chemicals are unlikely to present an unreasonable risk and may enter the market, according to recent Environmental Protection Agency analyses.
Solazyme Inc., which uses algae to make industrial chemicals, is authorized by EPA to make two of the three chemicals. Its chemicals, both glycerides (P-16-0340 and P-16-0351), will be used as lubricants or lubricant ingredients or to make other chemicals.
The manufacturer of the third chemical (P-16-0392) justified to the EPA's satisfaction its need to keep its name confidential. That company can now modify vegetable oil to produce a chemical that can serve several functions, including being a fuel, fuel additive, lubricant or lubricant additive.
The EPA's recent decisions on the three chemicals mean that as of Aug. 15 it has affirmatively approved the entry of seven new chemicals onto the market using criteria established by the new Frank R. Lautenberg Chemical Safety for the 21st Century Act, which amended Toxic Substances Control Act.
Prior to Lautenberg, TSCA did not require the EPA to make any specific finding when it reviewed chemical manufacturers' premanufacture notices (PMNs), forms companies must submit before they are allowed to make or import a new chemical in the U.S.
Subsequently, if the EPA took no action during the 90-day review period that TSCA provides for new chemicals, the new molecule simply could enter the market after the review period expired.
Now the EPA must review new chemicals using criteria—such as their risk to potentially exposed or susceptible populations—established by Lautenberg.
The amended law also requires the EPA to reach one of four decisions about each new chemical. The agency must find that either the chemical:
All seven of the new chemicals for which the agency has announced findings were deemed by the EPA to be “not likely to present an unreasonable risk.”
Chemical manufacturers have yet to see what concerns, lack of data or other factors would trigger any of the remaining three findings.
As of Aug. 15, the EPA was reviewing 416 premanufacture notices, an agency spokeswoman told Bloomberg BNA.
A total of 336 PMNs, including the seven for which the EPA has completed its analyses, were under review when President Obama signed the Lautenberg Act into law June 22, the EPA said.
The 90-day review period for those 336 PMNs was reset effective that day although the EPA repeatedly said it was trying to complete its analyses soon after they would have been finished had the law not been amended.
The EPA expects to soon publish a Federal Register notice identifying the premanufacture notices under review, the agency said.
Meanwhile, four Federal Register notices the EPA published since May 2 give some indication of the chemicals it is reviewing. Those notices show that the agency received at least 242 PMNs since March, including the seven it has since allowed to enter commerce.
According to these notices, the EPA received:
To contact the reporter on this story: Pat Rizzuto in Washington at email@example.com
To contact the editor responsible for this story: Larry Pearl at firstname.lastname@example.org
The EPA's findings for new chemicals are available at http://src.bna.com/hJL.
Copyright © 2016 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)